graduate companies
- Filter:
- All
- #
- a
- b
- c
- d
- e
- f
- g
- h
- i
- j
- k
- l
- m
- n
- o
- p
- q
- r
- s
- t
- u
- v
- w
- x
- y
- z
149 Medical
AAVPACK
Accurvec Biotech
AChemtek
Acotrix, Inc
Advanced Diagnostic Technologies
Agilux Laboratories
Alpha-Beta Technology, Inc.
Acquisition
Alpha-Beta was the second ever startup company to enter the MBI incubator. Alpha-Beta reached a peak headcount of 220 employees and peak market capitalization of $350 million, before being sold in 1999. Products developed by Alpha-Beta are now marketed as Wellmune by Kerry, a global health and nutrition company.
Learn more
Amachumu Bio
Anteros Bio
We're on a journey to help couples reclaim their intimacy by providing the first at-home genital microbiome test kit for couples that will help answers your questions about recurring UTIs, Yeast Infections, Inflammation, Discomfort and more.
Antigen Express, Inc
Acquired by Generex
Learn more
Antigen Targeting Consulting
Arogy Tx
Astraeus Technologies
Atoxin Biotech LLC
Attogen, Inc
Avatar Pharmaceuticals
Acquired by Vertex Pharmaceuticals
Learn more
Averica Discovery Services Inc
Beckman Coulter
Bio-Detail Corporation
BioChron, LLC
Biocytogen, LLC
IPO, $335M+
Learn more
Bioflash Partners, LLC
Acquired by Repligen
Learn more
BioFluentLabs
Bioheart
Bioinformatics.org
Biolyceum
Biomere
Acquired by JOINN Laboratories Co. Ltd.
Learn more
BioPact
BioTechnic Products LTD
Biotrofix, Inc.
Blue Sky Biotech, Inc
Acquired by Curia
Learn more
Boston Biokeys Corporation
Carepoint Solutions, Inc
Cell Mosaic
CellEdit, LLC
Clock Coach
Coley Pharmaceutical Group, Inc
Acquired by Pfizer
Learn more
Convergent Dental
$115M+ raised, commercialized product
Learn more
Creoptix
Crow’s Nest Bioventures & Greater Good Imperial Brewing, Co.
Cureport
CytoVera, Inc
DermBiont
Leveraging skin microbiome therapeutics to treat, cure, and prevent skin diseases. DermBiont is advancing targeted topical therapeutics for dermatological indications. Their products in development are all first-in-class with well-defined mechanisms of action and address the root cause of skin diseases.
DNX Resource Group, Inc
ECI Biotech
Edelweiss Immune
Novel therapeutics for autoimmune diseases. Edelweiss Immune is dedicated to developing novel therapeutics with better selectivity, safety, and efficacy for patients suffering autoimmune diseases such as multiple sclerosis, inflammatory arthritis, and psoriasis.
Eden Research
Enable Life Sciences
Enable Life Sciences facilitates Innovation in the life sciences. We bring the innovative plans and aspirations of our clients to reality through Planning, Creation and Execution. We enable success through customized Innovation Management and R&D Project Management services, including collaborations at a global scale. We serve a broad array of clients including those in medical devices, pharmaceuticals, biotechnology, diagnostics, mHealth and healthcare delivery industries.
Enrich Therapeutics
Entegrion, Inc
EpigenDx
Fluidform
GAMA Therapeutics
Gemini Medical, Inc.
Genome Quest, Inc
Gliese623B
Gliese623B provides consultant services in the areas of pre-clinical medical device validation support for 510K premarket notification submissions with the FDA. We also provide drug discovery solutions and manufacture support, study design & protocol development, pre-clinical method validation, R&D outsourcing, SOP authorship, risk assessments, and gap analysis. For developed programs we provide clinical trial and support through a network of medical teaching institutions and hospitals.
GlycoSolutions Corporation
Grove Instruments, Inc
HDL Therapeutics, Inc.
HelixBind
Histologistics
HSRL, Inc.
Acquired by StageBio
Learn more
Hypromatrix, Inc
Incite Advisors, Inc
Innolign Biomedical
Intelligent Biosystems
Invetx
IPO, $80M+
Learn more
iOmics Corporation
iVexSol
Series A
Learn more
Janus Biotherapeutics
JURA Bio, Inc.
At JURA Bio, we combine the next generation machine inference with the world’s largest high-quality biological datasets and autonomously optimized iterative design. The result? Drug discovery and development for genomic medicine as we’d only dreamed possible.
JuvoBio Pharmaceuticals
KBioBox, LLC
KeraCure, Inc
Leveragen
Leveragen is a Massachusetts-based biotech company specializing in genetic engineering. We develop comprehensive solutions for genetic modeling, creating designer mutations to study gene function and disease mechanisms.
Loop CO2
Loop CO2, inc. is a green chemistry research and development startup. The company is one of the grant awardees by Department of Energy. We are specialized in developing a new class of polyester materials in the form of pellets for manufacturing consumer products from a CO2-derived monomer feedstock.
Matrigen Life Technologies
MedTherapy Biotech
MICROBAC
MicroECM
MSM Protein Technologies
MyoSyntax
NanoBio Systems
Nemucore Medical Innovations, Inc
Niagara Biosciences
Nirogyone Therapeutics
NOMIR Medical Technologies
Nyla Laboratories
Acquired
Learn more
Olaf Pharmaceuticals
OptoGlo
OptoGlo has invented an advanced material that is radically changing the functionality of signs. Instantly display messaging and advertising without wires – day or night.
Or-Genix Therapeutics
Ostroff Consulting
Otomagnetics
PackGene Biotech, Inc.
Pananosis
A platform blood-based diagnostic test powered by computationally analyzing immune footprint patterns
Performance Indicator
Pharma Models, LLC
ProFoldin
Propel Biosciences
Provia Labs
Ravissanics, Inc
Robyn Robotics
RXI Pharmaceuticals
Seamless Therapeutics
Seamless Therapeutics is changing the paradigm of gene editing through a pioneering approach to restore health in patients with severe conditions in a safe and precise manner.
Solarea Bio
Solarea Bio is a biotech company building solutions for health disorders using bacteria and fungi native to healthy foods to create powerful synergistic, anti-inflammatory microbial assemblages.
Spring Bank Technologies
Stability Health
Stryker Orthobiologics
Suco, LLC
Sufacine Development Company
T2 Biosystems
Targeted Biosciences, Inc.
Tarpon Biosystems, Inc
Tech Acquisition by Pall
Learn more
Technical Innovation Center
Time Bioscience
TransCode Therapeutics
IPO, $7M
Learn more
TransCytos
uBriGene
uBriGene Bioscience Inc. is a leading contract development and manufacturing organization (CDMO), specializing in the development and application of cell and gene therapy technologies.
VecX Biomedicines
VecX Biomedicines is an AI-driven biotech company existing at the intersection of computational protein design, bioengineering, synthetic biology, and medicine and pioneering gene therapy to create breakthrough medicines.